Clinical Trials Browser

Phase 2 × iberdomide × 90 days × Clear all

NCT05272826 2026-03-18

BOREALIS

Phase 2 Recruiting

Multiple Myeloma

NCT06179888 2026-03-18

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

Phase 2 Recruiting

Multiple Myeloma

NCT05896228 2026-03-11

Iber-KDd

Phase 2 Recruiting

Multiple Myeloma